The Bacteriophage Mu Lysis System--A New Mechanism of Host
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
RIPA Buffer Lysis Protocol
PROVOST & WALLERT RESEARCH Investigating the Biochemistry and Cellular Physiology of NHE1 EST. 1998 Whole Cell Lysate Preparation using RIPA Buffer – for membrane and soluble proteins RIPA Buffer (Radio-Immune Precipitation Assay) is used to lyse cultured cells to prepare protein extraction from cytoplasmic, membrane and nuclear proteins. Samples prepared with RIPA Buffer can easily be used with a BCA protein assay, western blot, immuno assays or other biochemical determintion. To maintain proteins in the state at time of lysis it is critical to keep cells on ice and only use ice cold buffer throughout to reduce protease, kinase, phosphatase or other enzymatic activity of lysates. T-25 flasks: 1) Remove old media and rinse cells with 2-3 ml of ice cold PBS. 2) Tilt flask 1-2 min on ice to drain residual PBS and remove by aspiration. 3) Add 0.5 ml of ice cold PBS and scrape cells. Transfer to labeled chilled microfuge tube. 4) Rinse cells with additional 1 ml of PBS and add to scraped cells. 5) Centrifuge at 2,500 x g for 5 min at 4oC. Decant supernate, keep pelleted cells. 6) Resuspend pellet in 0.25 ml of RIPA Buffer – use a pipet tip to suspend cells. 7) Lyse cells by sonication for 2, 30 second pulses (50% power) while on ice. 8) Shake mixture gently on ice for 15 min. 9) Centrifuge samples at ~14,000 x g for 15 min to pellet cell debris. Keep supernatant soln. 10) Perform BCA (Pierce) NOT Bradford/biorad protein assay. RIPA Buffer 50 mM Tris-HCl, pH 7.4, 150 mM sodium chloride, 1 mM ethylenediaminetetraacetic acid (EDTA), 1% NP-40 1% Sodium Deoxycholic acid, 0.1% sodium dodecylsulfate (SDS), 1 mM phenylmethylsulfonyl fluoride, (add fresh) Protease Inhibitors (add fresh - see manufacturer’s instructions) . -
Electrical Lysis: Dynamics Revisited and Advances in On-Chip Operation
Critical Reviews™ in Biomedical Engineering, 41(1):37–50 (2013) Electrical Lysis: Dynamics Revisited and Advances in On-chip Operation Bashir I. Morshed,1,* Maitham Shams,2 & Tofy Mussivand3 1Department of Electrical & Computer Engineering, University of Memphis, Memphis, TN 38152; 2Department of Elec- tronics, Carleton University, Ottawa, ON, Canada; 3Medical Devices Innovation Institute, University of Ottawa, Ottawa, ON, Canada * Address all correspondence to: Bashir I. Morshed, Ph.D., Assistant Professor, 204C Engineering Science Building, Department of Electrical & Computer Engineering, University of Memphis, Memphis, TN 38152; Tel.: 901-678-3650; Fax: 901-678-5469: [email protected]. ABSTRACT: Electrical lysis (EL) is the process of breaking the cell membrane to expose the internal contents under an applied high electric field. Lysis is an important phenomenon for cellular analysis, medical treatment, and biofoul- ing control. This paper aims to review, summarize, and analyze recent advancements on EL. Major databases includ- ing PubMed, Ei Engineering Village, IEEE Xplore, and Scholars Portal were searched using relevant keywords. More than 50 articles published in English since 1997 are cited in this article. EL has several key advantages compared to other lysis techniques such as chemical, mechanical, sonication, or laser, including rapid speed of operation, ability to control, miniaturization, low cost, and low power requirement. A variety of cell types have been investigated for including protoplasts, E. coli, yeasts, blood cells, and cancer cells. EL has been developed and applied for decon- tamination, cytology, genetics, single-cell analysis, cancer treatment, and other applications. On-chip EL is a promis- ing technology for multiplexed automated implementation of cell-sample preparation and processing with micro- or nanoliter reagents. -
Optimal Control of Innate Immune Response
OPTIMAL CONTROL APPLICATIONS AND METHODS Optim. Control Appl. Meth., 2002; 23: 91–104 (DOI: 10.1002/oca.704) Optimal control of innate immune response Robert F. Stengel*, Raffaele Ghigliazza, Nilesh Kulkarni and Olivier Laplace School of Engineering and Applied Science, Princeton University, Princeton, NJ 08544, U.S.A SUMMARY Treatment of a pathogenic disease process is interpreted as the optimal control of a dynamic system. Evolution of the disease is characterized by a non-linear, fourth-order ordinary differential equation that describes concentrations of pathogens, plasma cells, and antibodies, as well as a numerical indication of patient health. Without control, the dynamic model evidences sub-clinical or clinical decay, chronic stabilization, or unrestrained lethal growth of the pathogen, depending on the initial conditions for the infection. The dynamic equations are controlled by therapeutic agents that affect the rate of change of system variables. Control histories that minimize a quadratic cost function are generated by numerical optimization over a fixed time interval, given otherwise lethal initial conditions. Tradeoffs between cost function weighting of pathogens, organ health, and use of therapeutics are evaluated. Optimal control solutions that defeat the pathogen and preserve organ health are demonstrated for four different approaches to therapy. It is shown that control theory can point the way toward new protocols for treatment and remediation of human diseases. Copyright # 2002 John Wiley & Sons, Ltd. KEY WORDS: optimal control; biological modelling; bioinformatics; optimization INTRODUCTION Immune-system response to invasion by infectious microbes is a dynamic process in which potentially uncontrolled growth of the invader (or pathogen) is countered by various protective mechanisms. -
Molecular Model for the Transposition and Replication of Bacteriophage
Proc. Natl. Acad. Sci. USA Vol. 76, No. 4, pp. 1933-1937, April 1979 Genetics Molecular model for the transposition and replication of bacteriophage Mu and other transposable elements (DNA insertion elements/nonhomologous recombination/site-specific recombination/replicon fusion/topoisomerases) JAMES A. SHAPIRO Department of Microbiology, The University of Chicago, Chicago, Illinois 60637 Communicated by Hewson Swift, December 11, 1978 ABSTRACT A series of molecular events will explain how B genetic elements can transpose from one DNA site to another, B y generate a short oligonucleotide duplication at both ends of the I % new insertion site, and replicate in the transposition process. I These events include the formation of recombinant molecules A a% /; C which have been postulated to be intermediates in the trans- position process. The model explains how the replication of bacteriophage Mu is obligatorily associated with movement to z x x new genetic sites. It postulates that all transposable elements replicate in the transposition process so that they remain at their z original site while moving to new sites. According to this model, the mechanism of transposition is very different from the in- V sertion and excision of bacteriophage X. y FIG. 1. Replicon fusion. The boxes with an arrow indicate copies Recent research on transposable elements in bacteria has pro- of a transposable element. The letters mark arbitrary regions of the vided important insights into the role of nonhomologous re- two replicons to indicate the relative positions of the elements in the combination in genetic rearrangements (1-4). These elements donor and cointegrate molecules. include small insertion sequences (IS elements), transposable resistance determinants (Tn elements), and bacteriophage Mu results in the duplication of a short oligonucleotide sequence (3). -
RBC Lysis Buffer Product Insert Product # 21201 (90 Ml) Product #21205 (500 Ml)
3430 Schmon Parkway Thorold, ON, Canada L2V 4Y6 Phone: 866-667-4362 • (905) 227-8848 Fax: (905) 227-1061 Email: [email protected] RBC Lysis Buffer Product Insert Product # 21201 (90 mL) Product #21205 (500 mL) Norgen’s RBC Lysis Buffer is designed for the differential lysis of red blood cells present in whole blood samples. The removal of red blood cells from whole blood is often desirable, particularly during the study of leukocyte DNA, proteins or RNA. Abundant proteins (including albumin) and RNAs (including globin mRNA) that are present in red blood cells and may interfere with downstream applications such as expression analysis are effectively removed during this process. For the procedure, whole blood samples are first collected in the presence of anticoagulants. The red blood cells are then removed through lysis using the RBC Lysis Buffer, and the leukocytes which remain can then be recovered by centrifugation. Genomic DNA, proteins or RNA can then be isolated from the purified leukocytes, as Norgen’s RBC Lysis Buffer is RNAase and DNase free. Product Components Component Product # 21201 Product # 2120 5 RBC Lysis Buffer 90 mL 500 mL Product Insert 1 1 Storage Conditions and Product Stability The RBC Lysis Buffer should be stored at 4°C. This reagent should remain stable for at least 1 year in its unopened container. Precautions and Disclaimers This reagent is designed for research purposes only. It is not intended for human or diagnostic use. Ensure that a suitable lab coat, disposable gloves and protective goggles are worn when working with chemicals. For more information, please consult the appropriate Material Safety Data Sheets (MSDSs). -
Antibody-Complement Cell Lysis LORNE A
INFECTION AND IMMUNITY, Nov. 1975, p. 958-963 Vol. 12, No. 5 Copyright © 1975 American Society for Microbiology Printed in USA. Defense Mechanisms Against Bovine Herpesvirus: Relationship of Virus-Host Cell Events to Susceptibility to Antibody-Complement Cell Lysis LORNE A. BABIUK, RICHARD C. WARDLEY, AND BARRY T. ROUSE* Department of Veterinary Microbiology, Western College of Veterinary Medicine, University of Saskatchewan, Saskatoon, Canada Received for publication 30 June 1975 The interaction of infectious bovine rhinotracheitis virus and susceptible host cells was examined to determine whether an infected cell could be destroyed by humoral immune mechanisms before or after the transmission of virus to susceptible adjacent cells. Viral antigens were detectable on cell membranes at 6 h postinfection, but cells were not susceptible to antibody-complement lysis until 10 h postinfection. Intracellular infectious virus was also detectable at 10 h postinfection, and transmission to adjacent cells by the intracellular route began at this time. Extracellular virus was not detectable until 12 to 13 h postinfection. By the continual addition of antibody and complement, virus dissemination could be reduced more than 50-fold. These results support the hypothesis that the humoral immune mechanism may be involved in the recovery from herpesvi- rus infections. Most herpesvirus infections are characterized seminated to susceptible adjacent cells. Subse- by recurrent infections, with the virus persist- quent communications will examine this ques- ing in the body almost indefinitely. In infec- tion with respect to other components of the tious bovine rhinotracheitis (IBR) infection of immune response. cattle, usually there is only a single episode of symptomatic infection; nevertheless, the virus MATERIALS AND METHODS does persist and can be reactivated (4, 15, 16). -
A Crude Extract Preparation and Optimization from a Genomically Engineered Escherichia Coli for the Cell-Free Protein Synthesis System: Practical Laboratory Guideline
Protocol A Crude Extract Preparation and Optimization from a Genomically Engineered Escherichia coli for the Cell-Free Protein Synthesis System: Practical Laboratory Guideline 1, 1, 1 1,2, Jeehye Kim y , Caroline E. Copeland y, Sahana R. Padumane and Yong-Chan Kwon * 1 Department of Biological and Agricultural Engineering, Louisiana State University, Baton Rouge, LA 70803, USA 2 Louisiana State University Agricultural Center, Baton Rouge, LA 70803, USA * Correspondence: [email protected]; Tel: +1-225-578-4325 These authors contributed equally to this work. y Received: 2 July 2019; Accepted: 7 August 2019; Published: 9 August 2019 Abstract: With the advancement of synthetic biology, the cell-free protein synthesis (CFPS) system has been receiving the spotlight as a versatile toolkit for engineering natural and unnatural biological systems. The CFPS system reassembles the materials necessary for transcription and translation and recreates the in vitro protein synthesis environment by escaping a physical living boundary. The cell extract plays an essential role in this in vitro format. Here, we propose a practical protocol and method for Escherichia coli-derived cell extract preparation and optimization, which can be easily applied to both commercially available and genomically engineered E. coli strains. The protocol includes: (1) The preparation step for cell growth and harvest, (2) the thorough step-by-step procedures for E. coli cell extract preparation including the cell wash and lysis, centrifugation, runoff reaction, and dialysis, (3) the preparation for the CFPS reaction components and, (4) the quantification of cell extract and cell-free synthesized protein. We anticipate that the protocol in this research will provide a simple preparation and optimization procedure of a highly active E. -
Enzymes for Cell Dissociation and Lysis
Issue 2, 2006 FOR LIFE SCIENCE RESEARCH DETACHMENT OF CULTURED CELLS LYSIS AND PROTOPLAST PREPARATION OF: Yeast Bacteria Plant Cells PERMEABILIZATION OF MAMMALIAN CELLS MITOCHONDRIA ISOLATION Schematic representation of plant and bacterial cell wall structure. Foreground: Plant cell wall structure Background: Bacterial cell wall structure Enzymes for Cell Dissociation and Lysis sigma-aldrich.com The Sigma Aldrich Web site offers several new tools to help fuel your metabolomics and nutrition research FOR LIFE SCIENCE RESEARCH Issue 2, 2006 Sigma-Aldrich Corporation 3050 Spruce Avenue St. Louis, MO 63103 Table of Contents The new Metabolomics Resource Center at: Enzymes for Cell Dissociation and Lysis sigma-aldrich.com/metpath Sigma-Aldrich is proud of our continuing alliance with the Enzymes for Cell Detachment International Union of Biochemistry and Molecular Biology. Together and Tissue Dissociation Collagenase ..........................................................1 we produce, animate and publish the Nicholson Metabolic Pathway Hyaluronidase ...................................................... 7 Charts, created and continually updated by Dr. Donald Nicholson. DNase ................................................................. 8 These classic resources can be downloaded from the Sigma-Aldrich Elastase ............................................................... 9 Web site as PDF or GIF files at no charge. This site also features our Papain ................................................................10 Protease Type XIV -
Bacterial Cell Lysis Buffer
Bacterial Cell Lysis Buffer INTRODUCTION The Bacterial Lysis kit has been developed for the extraction of soluble proteins and inclusion bodies from bacterial cells. It is a proprietary improvement on the lysozyme based lysis, which allows extraction of soluble proteins and concurrent removal of nucleic acids (DNA & RNA) released during cell lysis. The lysis eliminates viscosity build-up, allowing effective clarification with lower centrifugal force. This kit is provided with an optional protocol for the formation of spheroplast and removal of lytic enzyme (Lysozyme) prior to lysis and extraction of the bacterial proteins. Bacterial Lysis Buffer is based on organic buffering agents and utilizes a mild non-ionic detergent and a proprietary combination of various salts and agents to enhance extraction and stability of proteins. Depending on the application, additional agents such as reducing agents, chelating agent, and protease inhibitors may be added into Bacterial Lysis Buffer. This reagent has been tested for use with several widely used bacteria including E. coli strains. Bacterial Lysis Buffer eliminates the need for laborious mechanical lysis of bacterial cells and removal of DNA/RNA with nuclease treatments. The proprietary combination of this reagent provides a simple and versatile method of bacterial protein extraction and isolation of inclusion bodies. APPLICATIONS Suitable for preparation of spheroplast, lysis and extraction of proteins from bacterial cells and isolation of inclusion bodies. COMPATIBILITY Bacterial Lysis Buffer is compatible with most downstream applications including running various chromatography, gel electrophoresis applications, and protein folding procedures. ITEMS SUPPLIED: Item Bacterial Lysis Kit Bacterial Lysis Buffer [Cat # GB-176] [Cat # GB-177] Bacterial Lysis Buffer 100ml 500ml Bacterial Suspension Buffer 25ml ------ Lysozyme 2 x 0.5ml ------ STORAGE CONDITION The kit is shipped at ambient temperature. -
Bacterial Virus Ontology; Coordinating Across Databases
viruses Article Bacterial Virus Ontology; Coordinating across Databases Chantal Hulo 1, Patrick Masson 1, Ariane Toussaint 2, David Osumi-Sutherland 3, Edouard de Castro 1, Andrea H. Auchincloss 1, Sylvain Poux 1, Lydie Bougueleret 1, Ioannis Xenarios 1 and Philippe Le Mercier 1,* 1 Swiss-Prot group, SIB Swiss Institute of Bioinformatics, CMU, University of Geneva Medical School, 1211 Geneva, Switzerland; [email protected] (C.H.); [email protected] (P.M.); [email protected] (E.d.C.); [email protected] (A.H.A.); [email protected] (S.P.); [email protected] (L.B.); [email protected] (I.X.) 2 University Libre de Bruxelles, Génétique et Physiologie Bactérienne (LGPB), 12 rue des Professeurs Jeener et Brachet, 6041 Charleroi, Belgium; [email protected] 3 European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Wellcome Trust Genome Campus, Hinxton CB10 1SD, UK; [email protected] * Correspondence: [email protected]; Tel.: +41-22379-5870 Academic Editors: Tessa E. F. Quax, Matthias G. Fischer and Laurent Debarbieux Received: 13 April 2017; Accepted: 17 May 2017; Published: 23 May 2017 Abstract: Bacterial viruses, also called bacteriophages, display a great genetic diversity and utilize unique processes for infecting and reproducing within a host cell. All these processes were investigated and indexed in the ViralZone knowledge base. To facilitate standardizing data, a simple ontology of viral life-cycle terms was developed to provide a common vocabulary for annotating data sets. New terminology was developed to address unique viral replication cycle processes, and existing terminology was modified and adapted. -
Thermo Scientific Pierce Cell Lysis Technical Handbook Version 2
Thermo Scientific Pierce Cell Lysis Technical Handbook Featuring Cell Lysis Reagents and Detergents Version 2 To order, call 800-874-3723 or 815-968-0747. Outside the United States, contact your local branch office or distributor. Table of Contents Thermo Scientific Cell Fractionation Kits 25-37 Subcellular Fractionation Kit 25-26 Mem-PER® Eukaryotic Membrane 27-28 Protein Extraction Kit Mitochondria Isolation Kits 29-31 NE-PER® Nuclear and Cytoplasmic Extraction Kit 32-34 Cell Surface Protein Isolation Kit 35 Organelle Enrichment Kits 36-37 DNA Extraction 38 Yeast DNA Extraction Kit 38 Thermo Scientific Lyse and Go™ PCR Reagent 38 Detergents 39-43 Thermo Scientific Pierce Cell Lysis Reagents Introduction to Detergents 39-40 Selection Guide 1 Properties of Common Detergents 40 Thermo Scientific Surfact-Amps and Introduction to Protein Extraction 2-5 Surfact-Pak Detergents 41 Cell Lysis Methods 2-5 Specialized Detergents 41-43 Detergent Removal 43 Introduction to Thermo Scientific Cell Lysis Solutions 6-15 Protease Inhibitors 44-47 ® B-PER Bacterial Protein Extraction Reagents 7-9 Halt™ Protease Inhibitor Single-Use Cocktails 44-45 ® I-PER Insect Cell Protein Extraction Reagent 10 Halt Phosphatase Inhibitor Cocktails 45 ® M-PER Mammalian Protein Extraction Reagent 11 Halt Combined Cocktails 46 ® P-PER Plant Protein Extraction Reagent 12-13 Protein Stabilizing Cocktail 47 ® T-PER Tissue Protein Extraction Reagents 14 PMSF 47 ® Y-PER Yeast Protein Extraction Reagents 15 Soybean Trypsin Inhibitor 47 Buffers 16 Protein Refolding 48-49 RIPA Buffer 16 Pierce Protein Refolding Kit 48 Fusion Protein Purification 17-22 Inclusion Body Solubilization Reagent 49 Fusion Protein Purification Kits 17-22 GST Orientation Kit 22 Mammalian and Yeast β-Gal Kits 23-24 Thermo Scientific Pierce Cell Lysis Reagents Selection Guide Description Organisms/Samples Dialyze1 Compatibility Thermo Scientific Protein Assay Compatibility Notes B-PER Reagent Gram(-) bacteria, S. -
DNA Sequences at the Ends of the Genome of Bacteriophage Mu Essential for Transposition (Mini-Mus/Nudease BAL-31/DNA-Protein Interactions) MARTIEN A
Proc. Natl. Acad. Sci. USA Vol. 82, pp. 2087-2091, April 1985 Genetics DNA sequences at the ends of the genome of bacteriophage Mu essential for transposition (mini-Mus/nudease BAL-31/DNA-protein interactions) MARTIEN A. M. GROENEN, ERIK TIMMERS, AND PIETER VAN DE PUTTE Laboratory of Molecular Genetics, Leiden State University, Wassenaarseweg 64, 2333 AL Leiden, The Netherlands Communicated by Franklin W. Stahl, November 19, 1984 ABSTRACT We have determined the minimal DNA se- att L at quences the ends of the genome of bacteriophage Mu that 13 21 23 20 15 14 5 29 are required for its transposition. A mini-Mu was constructed Ill JI Il506 on a multicopy plasmid that enabled the manipulation of the 10 20 30 40 S0 do DNA sequences at its ends without affecting the genes essential 5 TGTATTGATT CACTTGAAGT ACGAAAAAAA CCGGGAGGAC ATTGGATTAT TCGGGATCTG for transposition. The genes A and B, which were cloned out- side the ends of the mini-Mu on the same plasmid, were both 70 80 90 100 110 120 needed for optimal transposition. In our experimental system ATGGGATTAG ATTTGGTG$ GCTTGCAAGC CTGTAGTGCA AATTTTAGTC CTTAATCAAT the predominant end products of the transposition are cointe- 28 4 27 24 26 11 1618 1 III 11 grates both in the presence and in the absence of B. Two re- 130 140 150 160 170 180 gions ending approximately 25 and 160 bp from the left end GAACGCGAA AGATAGTAM AAATTGCTTT TGTTTCATTG AAAATACGAA AAACAAAAAC and one ending approximately 50 bp from the right end appear to be essential for optimal transposition. Overlapping with these regions, a 22-base-pair sequence was recognized with the 190 200 210 220 consensus Y-G-T-T-T-C-A-Y-T-N-N-A-A-R-Y-R-C-G-A-A-A- ACTGCAAATC ATTTCAATAA CAGCTTCAAA AAACGTTCAA A, where Y and R represent any pyrimidine and purine, re- spectively.